Who are Cimicifuga Herbarium's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): an extract of Cimicifuga Foetida L., Pueraria lobata, Cimifuga Racemosa.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cimicifuga-herbarium.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Cimicifuga Herbarium — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cimicifuga Herbarium (Cimicifuga Herbarium) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / phytoestrogen. Area: Women's Health / Menopause.

phase 3 Herbal extract / phytoestrogen Women's Health / Menopause Small molecule Live · refreshed every 30 min

Target snapshot

Cimicifuga Herbarium (Cimicifuga Herbarium) — Phytopharm Consulting Brazil. Cimicifuga (black cohosh) herbarium extract modulates estrogen receptor signaling and reduces vasomotor symptoms through phytoestrogen activity.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Cimicifuga Herbarium TARGET	Cimicifuga Herbarium	Phytopharm Consulting Brazil	phase 3	Herbal extract / phytoestrogen
an extract of Cimicifuga Foetida L.	an extract of Cimicifuga Foetida L.	Shandong Luye Pharmaceutical Co., Ltd.	marketed	Herbal extract / phytoestrogen
Pueraria lobata	Pueraria lobata	Jiangxi University of Traditional Chinese Medicine	marketed	Herbal extract / Phytoestrogen
Cimifuga Racemosa	Cimifuga Racemosa	Federal University of Minas Gerais	marketed	Herbal extract / phytoestrogen

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / phytoestrogen class)

Federal University of Minas Gerais · 1 drug in this class
Phytopharm Consulting Brazil · 1 drug in this class
Shandong Luye Pharmaceutical Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cimicifuga Herbarium — Competitive Intelligence Brief. https://druglandscape.com/ci/cimicifuga-herbarium. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing